Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-11-18-Speech-2-258"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20031118.8.2-258"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spoken text |
". – First, I should like to thank the rapporteur and the Members of this House for their comments on this report. I can reassure you that cancer prevention still figures very high on my agenda. As some Members have rightly stated to me in writing, after 15 years of continuous European Community efforts and involvement, this represents a significant and visible success for the Community in an important area of disease prevention and health promotion for European citizens. Work on cancer, including screening and surveillance, will be taken forward by the Commission. The cancer screening recommendation will be taken forward by Member States' authorities and the Commission, once it is adopted by the Council. Funding will be through ongoing projects within the previous 'Europe Against Cancer' programme and through the new public health programme. For 2003, a number of cancer-related projects have been identified for funding. Under the current contracts, a fourth edition of the European guidelines for quality assurance in mammography screening and the first comprehensive edition of European guidelines for best practice in cervical cancer screening will be finalised in 2004.
In addition, Amendments 5, 13 and 34 cannot be supported. They refer to tests that have not been successfully evaluated in randomised controlled trials.
Finally, Amendment 33 cannot be accepted. Even though it makes the necessary distinction between evidence-based tests and new tests currently under evaluation or new variations of recommended tests, these new tests are already sufficiently covered by Articles 6(c) and (d). To mention a few specific ones would immediately raise the question as to why only those tests have been singled out.
The Commission has already enhanced the prevention of diseases, including cancer, in the new health programmes draft work programme for 2004.
The draft specifically provides for a reference to cancer under the first and third strand objectives. This will enable cancer surveillance applications to be fully considered. Project proposals on the status of best practice in the Member States, as well as in acceding countries, would also be covered.
In the light of the views expressed today, the Commission intends to review the situation of cancer prevention even further with regard to the public health programmes work programme of 2004. We will then have to decide how to best underpin the Commission's role in cancer prevention, while implementing the Council recommendation on cancer screening.
As the matter is especially important for acceding countries too, we are considering a meeting between experts from these countries and cancer screening experts, in order to ensure that the achievements of the cancer networks benefit the new Member States as well.
The points raised in the report and during the debate today have demonstrated clearly the importance of the issue. In the report of the Committee on Environment, Health and Consumer Protection, 33 amendments are proposed. A further amendment was tabled for the plenary session.
The Commission can in principle support 11 amendments, namely Amendments 2, 3, 4, 6, 7, 10, 11, 14, 15, 19, and 22. In addition, we partially support four amendments, Amendments 1, 29, 30 and 32.
In addition to general improvements in the wording of the text, the acceptable amendments concern, for example, improving compliance and equal access for European citizens, as well as enhancing the role of the Commission in following up the implementation of the Council recommendation. The Commission cannot, however, support the remaining 19 amendments.
Amendment 25 cannot be supported, as all rules and regulations on data protection in the Member States must be in accordance with Directive 95/46/EC. Exceptions, for instance for medical registries, must be in accordance with Article 8 of the directive. Thus the amendment would simply reiterate the 'acquis communitaire'."@en1
|
| lpv:unclassifiedMetadata |
Named graphs describing this resource:
The resource appears as object in 2 triples